Last $57.98 USD
Change Today +0.10 / 0.17%
Volume 11.5M
As of 6:40 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - merck & co. inc. (MRK)

Name (Connections)Board RelationshipsTitleKey Developments
Leslie Brun 48 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Governance, Public Policy & Corporate Responsibility CommitteeMerck & Co. Inc. Updates Status of VIOXX Litigation and SEC Inquiry
01/28/05
Wendell Weeks 39 RelationshipsDirector, Member of Audit Committee, Member of Governance, Public Policy & Corporate Responsibility Committee and Member of Research CommitteeSEC Announces Formal Probe of Merck's Vioxx Recall
02/8/05
Thomas Cech Ph.D. 11 RelationshipsIndependent Director, Member of Audit Committee and Member of Research Committee 
C. Kidder 75 RelationshipsDirector, Member of Audit Committee and Member of Research Committee 

Compensation Committee* - merck & co. inc. (MRK)

Name (Connections)Board RelationshipsTitle
Thomas Glocer 197 RelationshipsDirector, Chairman of Compensation & Benefits Committee and Member of Governance, Public Policy & Corporate Responsibility Committee
William Harrison Jr. 236 RelationshipsLead Director, Chairman of Governance, Public Policy & Corporate Responsibility Committee and Member of Compensation & Benefits Committee
Carlos Represas 47 RelationshipsDirector and Member of Compensation & Benefits Committee
Patricia Russo 115 RelationshipsDirector and Member of Compensation & Benefits Committee
Peter Wendell 19 RelationshipsDirector, Member of Research Committee and Member of Compensation & Benefits Committee
MRK Compensation vs. Industry
1.5M
373.9K
Chief Executive Officer
Share price activity for MERCK & CO. INC. (MRK)
52 Week Price Performance
MRK
Industry Average

Nominating Committee* - merck & co. inc. (MRK)

Name (Connections)Board RelationshipsTitleKey Developments
William Harrison Jr. 236 RelationshipsLead Director, Chairman of Governance, Public Policy & Corporate Responsibility Committee and Member of Compensation & Benefits CommitteeMerck & Co. Inc. Announces Executive Changes
12/19/14
Thomas Glocer 197 RelationshipsDirector, Chairman of Compensation & Benefits Committee and Member of Governance, Public Policy & Corporate Responsibility CommitteeMerck Appoints Julie Gerberding as Executive Vice President for Strategic Communications, Global Public Policy and Population Health
12/10/14
Leslie Brun 48 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Governance, Public Policy & Corporate Responsibility CommitteeMerck & Co Appoints Giri Giridhar as Senior Director (Finance) and Board Member for the Global Pharma India Arm
09/12/14
Craig Thompson M.D. 138 RelationshipsDirector, Chairman of Research Committee and Member of Governance, Public Policy & Corporate Responsibility CommitteeMerck Appoints Michael J. Holston as General Counsel, Effective July 01, 2015
06/23/14
Wendell Weeks 39 RelationshipsDirector, Member of Audit Committee, Member of Governance, Public Policy & Corporate Responsibility Committee and Member of Research CommitteeMerck Announces Executive Changes, Effective from April 23, 2014
03/27/14
Rochelle Lazarus 465 RelationshipsDirector and Member of Governance, Public Policy & Corporate Responsibility Committee

Corporate Governance Committee* - merck & co. inc. (MRK)

Name (Connections)Board RelationshipsTitle
Leslie Brun 48 RelationshipsDirector, Chairman of Compensation & Benefits Committee and Member of Governance, Public Policy & Corporate Responsibility Committee
Thomas Glocer 197 RelationshipsLead Director, Chairman of Governance, Public Policy & Corporate Responsibility Committee and Member of Compensation & Benefits Committee
William Harrison Jr. 236 RelationshipsDirector and Member of Compensation & Benefits Committee
Rochelle Lazarus 465 RelationshipsDirector and Member of Compensation & Benefits Committee
Craig Thompson M.D. 138 RelationshipsDirector, Member of Research Committee and Member of Compensation & Benefits Committee
Wendell Weeks 39 Relationships--
MRK and Competitor
Insiders vs. External
Board
8%
92%
Merck & Co. Inc.
7%
93%
Gilead Sciences Inc.
7%
93%
Pfizer Inc.
19%
81%
GlaxoSmithKline plc
6%
94%
Sanofi
14%
86%
Roche Holding AG
Insiders
External Board Members

Executive Committee* - merck & co. inc. (MRK)

Name (Connections)Board RelationshipsTitle
David Anstice 135 RelationshipsFormer Executive Vice President of Strategy Initiatives
Marcia Avedon Ph.D. 38 RelationshipsFormer Senior Vice President of Human Resources
Willie Deese 15 RelationshipsExecutive Vice President and President of Merck Manufacturing Division
Kenneth Frazier 41 RelationshipsChairman, Chief Executive Officer and President
Mirian Graddick-Weir Ph.D. 12 RelationshipsExecutive Vice President of Human Resources
Bridgette Heller 8 RelationshipsFormer Executive Vice President and President of Merck Consumer Care
Peter Kim Ph.D. 0 RelationshipsFormer Executive Vice President and President of Merck Research Laboratories
Judy Lewent 85 RelationshipsFormer Chief Financial Officer, Executive Vice President, Head of Strategic Planning and Member of Management Committee
Peter Löscher MBA 60 RelationshipsFormer Member of Management Committee and President of Global Human Health
Adel Mahmoud M.D., Ph.D. 102 RelationshipsFormer Chief Medical Advisor of Vaccines & Infectious Diseases
Margaret McGlynn R.Ph 56 RelationshipsFormer President of Merck Vaccines & Infectious Diseases
J. Scalet 7 RelationshipsFormer Chief Information Officer and Executive Vice President of Global Process & Services
Bradley Sheares Ph.D. 46 RelationshipsFormer Member of Management Committee, President of U S Human Health and President of USHH Operations
Per Wold-Olsen MBA 50 RelationshipsFormer Member of Executive Committee, President of Human Health-Europe, Middle East & Africa and President of Human Health -Europe, Middle East Africa, Latin America & Canada
Management Effectiveness Relative to the Industry
Return on Equity
0.4x
Return on Assets
0.7x
Return on Total Capital
0.7x
TEV/Total Revenue(LTM)
0.7x
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $57.98 USD +0.10

MRK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $103.42 USD +0.355
GlaxoSmithKline PLC 1,571 GBp +5.00
Pfizer Inc $34.47 USD -0.17
Roche Holding AG SFr.256.10 CHF -4.10
Sanofi €87.84 EUR +0.39
View Industry Companies
 

Industry Analysis

MRK

Industry Average

Valuation MRK Industry Range
Price/Earnings 14.2x
Price/Sales 3.9x
Price/Book 3.4x
Price/Cash Flow 13.8x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.